What’s the difference between Xopenex and albuterol?
Xopenex is the brand name for levalbuterol, while albuterol is the generic name (often sold under brands like ProAir, Ventolin, and others depending on formulation). Both medications are short-acting beta-2 agonists used to relieve bronchospasm, such as from asthma or COPD.
The key difference is how the drug is made:
- Albuterol contains a mix of two mirror-image forms (enantiomers).
- Levalbuterol contains the active enantiomer (the part that directly drives the bronchodilator effect).
Because of that, some clinicians prefer levalbuterol when patients do not respond well to albuterol or experience side effects, but both are intended to improve airflow quickly.
Do they work equally well for asthma or COPD?
Both levalbuterol (Xopenex) and albuterol are used for quick relief of symptoms. In practice, many patients get similar symptom relief with either drug. The choice often comes down to:
- individual response (some people feel better with one than the other)
- side effects (like tremor or faster heart rate)
- what your clinician and local formulary prefer
How are side effects different?
Since they are in the same medication class, side effects can overlap. Common beta-agonist effects include:
- tremor
- nervousness
- headache
- palpitations or increased heart rate
- sometimes lightheadedness
Some patients report fewer side effects with levalbuterol than with racemic albuterol, but results can vary person to person.
Which one should you use if you’re switching?
If you’re switching due to lack of relief or side effects, the safest approach is:
- follow your prescriber’s guidance on the new dosing and device (inhaler vs nebulizer)
- don’t assume the doses are identical across products or formulations
The right switch depends on the exact prescription (concentration for nebulizer solutions, and inhaler strength and dosing frequency).
What about cost and insurance coverage?
Coverage is highly variable by plan and region. In general, brand-name Xopenex may cost more than generic albuterol, while generics can lower out-of-pocket cost. Many patients end up choosing albuterol unless their clinician documents a reason to use levalbuterol.
If you want, tell me your specific form (metered-dose inhaler vs nebulizer) and the strength you have, and I can help you compare dosing units you’d typically see.
Are there patent/exclusivity differences?
Levalbuterol’s patent and market history differ from albuterol’s generics because albuterol has long had generic versions. For up-to-date patent and exclusivity tracking (and to see which markets/products are covered), DrugPatentWatch.com can be a useful reference: DrugPatentWatch.com.
Quick practical bottom line
- Xopenex (levalbuterol) and albuterol are both short-acting rescue bronchodilators.
- Xopenex is essentially the “active” form of albuterol, so some patients tolerate it better or respond differently.
- Which is better depends on your personal response, side effects, and insurance/formulary.
If you share what you’re using it for (asthma vs COPD), the form (inhaler/nebulizer), and your current dose, I can tailor a more direct comparison for your situation.